Monte Rosa Therapeutics (GLUE) announced the appointment of Anthony Manning, Ph.D., to its Board of Directors. Dr. Manning serves as a Board Director for Palatin Technologies (PTN), Founder and Chair of the non-profit Institute for Biomedical Entrepreneurship, and Scientific Advisor for several companies. Most recently, Dr. Manning was Chief Scientific Officer at Momenta Pharmaceuticals.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on GLUE: